Patient selection for high-dose chemotherapy in stage II and IV breast cancer

Patient selection for high-dose chemotherapy in stage II and IV breast cancer

Authors	J.G. Schrama
Supervisors	S. Rodenhuis
Award date	14-10-2004
ISBN	9064646104 9789064646102
Number of pages	160
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	Research conducted at: AvL/NKI
Language	English
Downloads	Thesis Cover Titlepage Table of contents Chapter 1. Introduction Chapter 2. Dose-intense chemotherapy for locally advanced breast cancer Chapter 3. Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement - final analysis with 7 years of follow-up Chapter 4. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer Chapter 5. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer Chapter 6. Toxicity of the high-dose chemotherapy CTC-regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institution Experience. Chapter 7. Palliative chemotherapy after failure of high-dose chemotherapy in breast cancer-toxicity and efficacy Chapter 8. Overexpression and amplification of Her-2 and Topoisomerase II alpha and the response to alkylating high-dose chemotherapy in stage IV breast cancer Chapter 9. Summary Chapter 10. Samenvatting in het Nederlands Dankwoord Curriculum vitae Stellingen behorend bij het proefschrift Cover
Permalink to this page

Back

UvA-DARE

Digital Academic Repository

Patient selection for high-dose chemotherapy in stage II and IV breast cancer